LY294002 --- PI3K/BET Dual Inhibitor
Overview | |
Catalog # | bs-60157c-5mg-solid |
Product Name | LY294002 --- PI3K/BET Dual Inhibitor |
Specifications | |
Storage Buffer | Powder |
Storage Condition | Store in dry, dark place at -20C for 1 year. |
Target | |
Product Information | Molecular Weight: 307.34 Formula: C19 H17 N O3 CAS Number: 154447-36-6 InChi Key: CZQHHVNHHHRRDU-UHFFFAOYSA-N InChi: InChI=1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2 Smiles: O=C1C=C(OC2C1=CC=CC=2C1C=CC=CC=1)N1CCOCC1 Purity: 98.0 Solubility: DMSO up to 100 mM Appearance: Solid Power. Shelf Life: 1.0 years |
Description | LY294002 is a potent and selective small molecule PI3K inhibitor, inhibits PI3Kα/δ/β with IC50 of 0.5 μM, 0.57 μM and 0.97 μM, respectively. It is the most widely used PI3K inhibitor to study the role of phosphoinositide 3-kinases in the signal transduction pathways involved in cell migration, proliferation, survival, and metabolism. LY294002 inactivates Akt/PKB, consequently inhibiting cell proliferation and inducing apoptosis. It is more stable in solution than Wortmannin, and also blocks autophagosome formation. Quantitative chemoproteomic profiling shows that LY294002 inhibits the BET bromodomain proteins BRD2, BRD3, and BRD4 with IC50 ~1-2 µM. It competitively inhibits acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell extracts. LY294002 provides a starting point for the generation of bromodomain inhibitors tapping the chemical space of kinase antagonists. |